1. Peter B, Karmin K. Clinical sports medicine. 2002. 2nd ed. Australia: McGraw-Hill;439–440.
2. Peter B, Karmin K. Clinical sports medicine. 2002. 2nd ed. Australia: McGraw-Hill;457.
4. Witvrouw E, Bellemans J, Lysens R, Danneels L, Cambier D. Intrinsic risk factors for the development of patellar tendinitis in an athletic population: a two-year prospective study. Am J Sports Med. 2001. 29:190–195.
Article
5. Kannus P. Etiology and pathophysiology of chronic tendon disorders in sports. Scand J Med Sci Sports. 1997. 7:78–85.
Article
7. Kannus P, Jozsa L, Natri A, Jarvinen M. Effects of training, immobilization and remobilization on tendons. Scand J Med Sci Sports. 1997. 7:67–71.
Article
8. Lecomte J, Buyse H, Taymans J, Monti T. Treatment of tendinitis and bursitis: a comparison of nimesulide and naproxen sodium in a double-blind parallel trial. Eur J Rheumatol Inflamm. 1994. 14:29–32.
9. Dreiser RL, Ditisheim A, Charlot J, Lopez A. A double blind, placebo controlled study of niflumic acid gel in the treatment of acute tendinitis. Eur J Rheumatol Inflamm. 1991. 11:38–45.
10. Almekinders LC, Temple JD. Etiology, diagnosis, and treatment of tendonitis: an analysis of the literature. Med Sci Sports Exerc. 1998. 30:1183–1190.
Article
11. Koen P, Roeland L. Patellar tendinopathy in athletes: current diagnosis and therapeutic recommendations. Sports Med. 2005. 35:71–87.
12. Peter B, Karmin K. Clinical sports medicine. 2002. 2nd ed. Australia: McGraw-Hill;517–519.
13. Peter B, Karmin K. Clinical sports medicine. 2002. 2nd ed. Australia: McGraw-Hill;391–392.